C07K 2319/06
Containing a lysosomal/endosomal localisation signal
Official title: containing a lysosomal/endosomal localisation signal
C07K2319/06 (Containing a lysosomal/endosomal localisation signal) appears on 116 US grants and 225 published applications in this corpus.
Search patents in C07K- Granted patents
- 116
- Published applications
- 225
- Assignees
- 103
- Inventors
- 318
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 3 |
| 2005 | 1 | 0 |
| 2006 | 0 | 7 |
| 2007 | 0 | 3 |
| 2008 | 2 | 1 |
| 2009 | 4 | 6 |
| 2010 | 5 | 5 |
| 2011 | 0 | 11 |
| 2012 | 4 | 6 |
| 2013 | 6 | 5 |
| 2014 | 3 | 7 |
| 2015 | 2 | 10 |
| 2016 | 6 | 13 |
| 2017 | 10 | 14 |
| 2018 | 5 | 14 |
| 2019 | 6 | 16 |
| 2020 | 12 | 19 |
| 2021 | 13 | 17 |
| 2022 | 7 | 16 |
| 2023 | 8 | 13 |
| 2024 | 9 | 18 |
| 2025 | 5 | 13 |
| 2026 | 4 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- RNA-guided nucleic acid modifying enzymes and methods of use thereof26 May 2026US 12,637,691 B2The Regents of the University of California
- Peptide saporin conjugate for the treatment of cancer17 Mar 2026US 12,576,157 B2SRI International
- Polypeptide assemblies and methods for the production thereof10 Feb 2026US 12,545,903 B2University of Utah Research Foundation
- KRAS variant mRNA molecules20 Jan 2026US 12,528,855 B2CureVac AG
- Peptide directed protein knockdown30 Sep 2025US 12,428,456 B2The University of British Columbia
- Use of chimera in targeted protein degradation technology17 Sep 2026US 2026/0274986 A1Sun Yat-Sen University
- Aav particles comprising liver-tropic capsid protein and acid alpha-glucosidase and use to treat pompe disease14 May 2026US 2026/0131031 A1CANbridge Pharmaceuticals, Inc.
- Treatment of nervous system injury and neurodegenerative disorders and related conditions19 Mar 2026US 2026/0078156 A1The Cleveland Clinic Foundation
- Retinal pigment epithelial (rpe) cell-directed peroxidase-based compositions, methods, and systems5 Mar 2026US 2026/0061036 A1Lysoclear, Inc.
- Biological product, method and application thereof5 Feb 2026US 2026/0035678 A1Shanghai Jenomed Biotech Co., Ltd.
Most cited
By later US patents
- Synthetic plant genes242US 5,500,365 AMonsanto Company · 1996
- Synthetic plant genes from BT kurstaki and method for preparation107US 5,880,275 AMonsanto Company · 1999
- Lysosomal targeting of immunogens62US 5,633,234 AThe Johns Hopkins University · 1997
- Subcellular targeting of therapeutic proteins62US 7,396,811 B2ZyStor Therapeutics, Inc. · 2008
- Targeted therapeutic proteins60US 7,560,424 B2ZyStor Therapeutics, Inc. · 2009